ARCHIVES

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

In Brief: NTP Invites Comments On Annual Carcinogen Report At April 21 Meeting; Robert Mosely Dies

March 27, 1987

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979

CCOP Q&A, List Of Research Bases

September 10, 1982

Garb’s Questions, Answers About Cancer Program

December 12, 1980